[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.166.74.94. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Views 234
Citations 0
Letters
August 1, 2012

Radiation Therapy Modalities for Prostate Cancer

Author Affiliations
 

Letters Section Editor: Jody W. Zylke, MD, Senior Editor.

Author Affiliations: University of Florida Proton Therapy Institute, Jacksonville, Florida (Dr Mendenhall; menden@shands.ufl.edu); Mayo Clinic, Rochester, Minnesota (Dr Schild); and Loma Linda University Medical Center, Loma Linda, California (Dr Slater).

JAMA. 2012;308(5):450. doi:10.1001/jama.2012.8112

To the Editor: Dr Sheets and colleagues1 used the Surveillance, Epidemiology, and End Results (SEER)-Medicare database to retrospectively compare surrogate outcomes (claims) for patients with non–metastatic prostate cancer treated with 3 radiation modalities—conformal radiation therapy, IMRT, and proton therapy—advances expected to improve disease control and toxicity outcomes through improved radiation dose distribution.

First Page Preview View Large
First page PDF preview
First page PDF preview
×